Experiment 440338

Worktypes

EFFECTS DUE TO A COMBINATION OF DRUGSANTICANCER AND/OR CYTOTOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VITRO

Compounds isolated

TAXOL

Alerts

THESE DATA ARE FROM A REVIEW ARTICLE.A MIXTURE OF PURE COMPOUNDS WAS USED TO OBTAIN THE REPORTED EFFECT.

Details

PropertyValue
Pharmacology
CYTOTOXIC ACTIVITY
OrganismEmpty organism
CitationHOLMES,FA:. (1993). TAXOL, SINGLE-AGENT AND COMBINATION THERAPY, FOR METASTATIC BREAST CANCER.. 11(1)
Amount utilized
Compound isolated
DiseaseDISCUSSED IN THIS REVIEW ARTICLE ARE 2 PHASE STUDIES, SEVERAL PHASE 1 STUDIES, 2 OF WHICH EVALUATED TAXOL TREATMENT IN COMBINATION WITH DOXORUBICIN AND SEVERAL IN VITOR STUDIES WITH TAXOL ALONE AND IN COMBINATION WITH DOXORUBICIN. TAXOL TREATMENT IN COMBINATION WITH DOXORUBICIN PROVED MORE EFFECTIVE IN THE TREATMENT OF CANCERS BOTH IN VIVO AND IN VITRO.
Number3
Qualitative result.
AnimalCELL CULTURE
Dose expressionCONC USED